Page last updated: 2024-12-04

mellitic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mellitic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

mellitic acid : A benzene-derived hexacarboxylic acid in which each carbon of benzene carries a carboxy substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2334
CHEMBL ID1231329
CHEBI ID41089
SCHEMBL ID22971
MeSH IDM0064516

Synonyms (34)

Synonym
AKOS001116892
CHEMBL1231329
chebi:41089 ,
nsc-229358
mellic acid
hexacarboxybenzene
517-60-2
nsc229358
mellitic acid
benzenehexacarboxylic acid
1,3,4,5,6-benzenehexacarboxylic acid
mellitic acid, 99%
1BQ4
DB01681
benzene hexacarboxylic acid
B0246
benzene-1,2,3,4,5,6-hexacarboxylic acid
1,2,3,4,5,6-benzenehexacarboxylic acid
nsc 229358
einecs 208-243-6
unii-p80qsp14dm
p80qsp14dm ,
FT-0622642
SCHEMBL22971
mellitic acid [mi]
YDSWCNNOKPMOTP-UHFFFAOYSA-N
mfcd00002469
DTXSID50199650
AS-64036
YSWG055
Q734078
EN300-18764
CS-0169857
Z90123533

Research Excerpts

Effects

ExcerptReferenceRelevance
"Mellitic acid, which has already been shown to be an effective inhibitor of dental calculus in experimental animals may also have some other properties that could be of advantage to its use in humans."( An investigation of the effects of mellitic acid on hydroxyapatite.
Leach, SA, 1978
)
1.26

Treatment

ExcerptReferenceRelevance
"Mellitic acid treatment of hydroxyapatite inhibited its ability to "seed" metastable solutions of calcium phosphate."( An investigation of the effects of mellitic acid on hydroxyapatite.
Leach, SA, 1978
)
1.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hexacarboxylic acidAn oxoacid containing six carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain D, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)Saccharomyces cerevisiae (brewer's yeast)Ki6.00004.00005.00006.0000AID977610
Chain A, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)Saccharomyces cerevisiae (brewer's yeast)Ki6.00004.00005.00006.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1999Journal of molecular biology, Jun-18, Volume: 289, Issue:4
Polyanionic inhibitors of phosphoglycerate mutase: combined structural and biochemical analysis.
AID1811Experimentally measured binding affinity data derived from PDB1999Journal of molecular biology, Jun-18, Volume: 289, Issue:4
Polyanionic inhibitors of phosphoglycerate mutase: combined structural and biochemical analysis.
AID631930Dissociation constant, pKa of the compound2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID631927Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (19.05)18.7374
1990's5 (23.81)18.2507
2000's4 (19.05)29.6817
2010's8 (38.10)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.81 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index62.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]